(Q39723185)

14 September 2017

1 reference

title

The presentation and management of endocrine ophthalmopathy (English)

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

25 June 2022

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

25 June 2022

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

25 June 2022

author name string

C. A. Gorman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A348357

25 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=348357

25 June 2022

publication date

1 March 1978

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:S0300595X7880036X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

https://api.elsevier.com/content/article/PII:S0300595X7880036X?httpAccept=text/plain

25 June 2022

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

Clinics in Endocrinology and Metabolism

25 June 2022

published in

1 reference

14 September 2017

volume

7

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

67-96

1 reference

Evidence To Suggest That LATS Protector Stimulates the Human Thyroid Gland

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Stimulation of the human thyroid by infusions of plasma containing LATS protector.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Pterional orbital decompression in progressive ophthalmopathy of Graves' disease. I. Short-term effects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Pterional orbital decompression in progressive ophthalmopathy of Graves' disease II. A follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Pterional approach for orbital decompression.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Ophthalmopathy of Graves' disease. Outcome after treatment with radioactive iodine, surgery, or antithyroid drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Radioactive iodine therapy for progressive malignant exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Complications of thyroid surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Extraocular muscle recessions utilizing silicone tendon prostheses.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Experimental ocular effects of high-voltage radiation from the betatron

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Malignant exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

The triiodothyronine suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Immunosuppressive therapy for the eye changes of Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Critical study of 5% guanethidine in ocular manifestations of Graves's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Pseudotumor of the Orbit and Limited Wegener's Granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Thyroid disease and glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Abnormalities in Thyroid Function in Relatives of Patients with Graves' Disease and Hashimoto's Thyroiditis: Lack of Correlation with Inheritance of HLA-B8

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Optic neuropathy of Graves disease, hyperthyroidism, and ocular myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Radiation Therapy for Exophthalmos: Report of Seven Cases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Evaluation of unilateral exophthalmos with ultrasonography: Analysis of 258 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

[Involvement of the optic nerve in endocrine edematous exophthalmos]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Selection of patients and choice of operation for orbital decompression in graves ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Supervoltage orbital radiotherapy for Graves' ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Asymmetric exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Plastic implants in muscle surgery. Plastic materials in the management of extraocular motility restrictions

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Lesions of the Orbit Affecting Motility

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Dysthyroid Ophthalmopathy: Orbital Evaluation with B-Scan Ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Appearance of unilateral infiltrative exophthalmos of Graves' disease after the successful treatment of the same process in the contralateral eye by apparently total surgical hypophysectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Methylprednisolone in the treatment of exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Topical Guanethidine Therapy for Endocrine Lid Retraction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Depot-methylprednisolone for subconjunctival and retrobulbar injections

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Optic neuropathy of graves's disease. Treatment by transantral or transfrontal orbital decompression.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Effects of beta blockade on the peripheral manifestations of thyrotoxicosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Evaluation of Exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Relationship of orbital sialic to endocrine exophthalmos.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Ophthalmic Graves' disease. Diagnosis and pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

PTERIONAL APPROACH TO THE ORBITS FOR DECOMPRESSION OR TUMOR REMOVAL

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Visual field defects in exophthalmos associated with thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Optic neuropathy of exophthalmic goiter (Graves' disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

RELIEF OF EYELID RETRACTION: A SURGICAL PROCEDURE.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Triiodothyronine levels in patients with euthyroid endocrine exophthalmos and during treatment of thyrotoxicosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

A combined approach for the diagnosis of orbital disease. Computed tomography and standardized A-scan echography

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Visual changes in progressive exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

The orbit: a review of the literature for 1961.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Pituitary Secretion of Free Alpha and Beta Subunit of Human Thyrotropin in Patients with Thyroid Disorders1

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Radioisotopic thyroidolymphography in patients with Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Studies on the pathogenesis of the ophthalmopathy of Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Dysthyroid ocular myopathy. Anatomy, histology, and electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Cell-Mediated Immunity in Graves' Disease and in Hashimoto's Thyroiditis as Shown by the Demonstration of Migration Inhibition Factor (MIF)1

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Graves' disease without hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Role of mucopolysaccharides in pathogenesis of experimental exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

The interaction of collagen and acid mucopolysaccharides. A model for connective tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Thyroid Responsiveness in Gravesian Ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Expanding lesions of the orbit. A clinical study of 230 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Lack of T-cell immune abnormalities in peripheral blood lymphocytes in patients with Graves' disease or hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Glucocorticoid Treatment of Progressive Infiltrative Ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Cell-Mediated Immunity in the Exophthalmos of Graves' Disease as Demonstrated by the Migration Inhibition Factor (MIF) Test*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

PROGRESSIVE EXOPHTHALMOS FOLLOWING THYROIDECTOMY; ITS PATHOLOGY AND TREATMENT

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Transantral orbital decompression for progressive exophthalmos. A follow-up of 54 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

UNILATERAL EXOPHTHALMOS WITH SPECIAL REFERENCE TO ENDOCRINE EXOPHTHALMOS AND PSEUDOTUMOR

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Retrobulbar connective tissue in TSH-induced exophthalmos in the crucian carp (Carassius carassius L.).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Malignant exophthalmos: a quantitative analysis of the orbital tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Surgical Management of Ocular Complications of Graves' Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Endocrine ophthalmoplegia. With an electromyographic study of paretic extraocular muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Endocrine exophthalmos during lithium therapy of manic-depressive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Stimulation of glucose utilization and glycosaminoglycans production by fibroblasts derived from retrobulbar tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Thyroid-stimulating immunoglobulins in Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Identification of Subgroups of Euthyroid Graves's Ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Eye signs in hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Fascia in Relation to Extraocular Muscle Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Radiometric Measurement of Thyroglobulin-Antithyroglobulin Immune Complex in Human Serum

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Serum Thyroglobulin Levels in Healthy Subjects and in Patients with Thyroid Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

The role of autoimmunity in hypoendocrine and hyperendocrine function: with special emphasis on autoimmune thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Lesions of the optic nerve in exophthalmos of endocrine origin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Transantral orbital decompression for malignant exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

[Measurement of ocular pressure, resistance to the flow of aqueous humor and rigidity in endocrine exophthalmias]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Retrobulbar connective tissue changes in malignant exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Euthyroid patients with early eye signs of Graves' disease; their responses to L-triiodothyronine and thyrotropin.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Classification of the eye changes of Grave's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Distribution of serum radioiodinated compounds in euthyroid and hyperthyroid patients following hypophysectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Ultrasonographic evidence of a consistent orbital involvement in Graves's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Total thyroid ablation: A prerequisite to orbital decompression for graves disease ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Increased urinary excretion of acidic mucopolysaccharides in exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

The binding of ( 3 H)thyrotropin and an 3 H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Ophthalmopathy Without Hyperthyroidism in Patients with Histologic Hashimoto's Thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2878%2980036-X

7 January 2021

Prednisone treatment in endocrine ophthalmopathy

6

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

CORTISONE in exophthalmos: report on a therapeutic trial of cortisone and corticotrophin (A.C.T.H.) in exophthalmos and exophthalmic ophthalmoplegia by a panel appointed by the Medical Research Council

3 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

Ophthalmopathy associated with primary hypothyroidism

3 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

The oculorotary muscles in Graves' disease

3 April 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

Pathogenesis and treatment of endocrine exophthalmos

3 April 2023

60

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

Medical approach to ophthalmopathy of Graves' disease

3 April 2023

76

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

Radiological signs in proptosis

3 April 2023

93

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

The orthoptic management of exophthalmic ophthalmoplegia

3 April 2023

97

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

Ophthalmic Graves' disease

3 April 2023

101

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator

3 April 2023

113

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

Surgical treatment of dysthyroid restriction syndromes

3 April 2023

117

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

A review of the surgical treatment of the ophthalmopathy of Graves' disease with emphasis on newer techniques in lid surgery

3 April 2023

134

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(78)80036-X

3 April 2023

Identifiers

0 references

1 reference